Non-Hodgkin's lymphomas clinical practice guidelines in oncology

Andrew D. Zelenetz; Jeremy S. Abramson; Ranjana H. Advani; C. Babis Andreadis; John C. Byrd; Myron S. Czuczman; Luis Fayad; Andres Forero; Martha J. Glenn; Jon P. Gockerman; Leo I. Gordon; Nancy Lee Harris; Richard T. Hoppe; Steven M. Horwitz; Mark S. Kaminski; Youn H. Kim; Ann S. Lacasce; Tariq I. Mughal; Auyporn Nademanee; Pierluigi Porcu; Oliver Press; Leonard Prosnitz; Nashitha Reddy; Mitchell R. Smith; Lubomir Sokol; Lode Swinnen; Julie M. Vose; William G. Wierda; Joachim Yahalom; Furhan Yunus

doi:10.6004/jnccn.2010.0021

Non-Hodgkin's lymphomas clinical practice guidelines in oncology

Andrew D. Zelenetz, Jeremy S. Abramson, Ranjana H. Advani, C. Babis Andreadis, John C. Byrd, Myron S. Czuczman, Luis Fayad, Andres Forero, Martha J. Glenn, Jon P. Gockerman, Leo I. Gordon, Nancy Lee Harris, Richard T. Hoppe, Steven M. Horwitz, Mark S. Kaminski, Youn H. Kim, Ann S. Lacasce, Tariq I. Mughal, Auyporn Nademanee, Pierluigi PorcuOliver Press, Leonard Prosnitz, Nashitha Reddy, Mitchell R. Smith, Lubomir Sokol, Lode Swinnen, Julie M. Vose, William G. Wierda, Joachim Yahalom, Furhan Yunus

Research output: Contribution to journal › Review article › peer-review

205 Scopus citations

Abstract

Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of lymphoproliferative disorders originating in B-lymphocytes, T-lymphocytes, or natural killer lymphocytes. An estimated 65,980 new cases of NHL were diagnosed in 2009, and 19,500 patients died of the disease. The median age of individuals with NHL has risen in the past 2 decades, resulting in a patient population that may also have significant comorbid conditions, complicating treatment options. These guidelines reflect significant updates, including the addition of a new guideline for adult T-cell leukemia/lymphoma, modifications to several treatment options for various lymphomas, and the inclusion of new therapies that recently received FDA approval.

Original language	English (US)
Pages (from-to)	288-334
Number of pages	47
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	8
Issue number	3
DOIs	https://doi.org/10.6004/jnccn.2010.0021
State	Published - Mar 2010

Keywords

Chronic lymphocytic leukemia
Cutaneous T-cell lymphoma
Diagnosis
Diffuse large B-cell lymphoma
Follicular lymphoma
Hematopathology
Immunohistochemistry
Lymphoma pathology
Mantle cell lymphoma
Marginal zone lymphoma
Mucosa-associated lymphoid tissue lymphoma
Mycosis fungoides
NCCN clinical practice guidelines
Non-Hodgkin's lymphoma
Peripheral
Staging evaluation
Sézary syndrome
T-cell lymphoma
Treatment
Treatment guidelines

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2010.0021

Cite this

Zelenetz, A. D., Abramson, J. S., Advani, R. H., Babis Andreadis, C., Byrd, J. C., Czuczman, M. S., Fayad, L., Forero, A., Glenn, M. J., Gockerman, J. P., Gordon, L. I., Harris, N. L., Hoppe, R. T., Horwitz, S. M., Kaminski, M. S., Kim, Y. H., Lacasce, A. S., Mughal, T. I., Nademanee, A., ... Yunus, F. (2010). Non-Hodgkin's lymphomas clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 8(3), 288-334. https://doi.org/10.6004/jnccn.2010.0021

Zelenetz, AD, Abramson, JS, Advani, RH, Babis Andreadis, C, Byrd, JC, Czuczman, MS, Fayad, L, Forero, A, Glenn, MJ, Gockerman, JP, Gordon, LI, Harris, NL, Hoppe, RT, Horwitz, SM, Kaminski, MS, Kim, YH, Lacasce, AS, Mughal, TI, Nademanee, A, Porcu, P, Press, O, Prosnitz, L, Reddy, N, Smith, MR, Sokol, L, Swinnen, L, Vose, JM, Wierda, WG, Yahalom, J & Yunus, F 2010, 'Non-Hodgkin's lymphomas clinical practice guidelines in oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 8, no. 3, pp. 288-334. https://doi.org/10.6004/jnccn.2010.0021

@article{1505b885325a464aa0d1a4d28da33abd,

title = "Non-Hodgkin's lymphomas clinical practice guidelines in oncology",

abstract = "Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of lymphoproliferative disorders originating in B-lymphocytes, T-lymphocytes, or natural killer lymphocytes. An estimated 65,980 new cases of NHL were diagnosed in 2009, and 19,500 patients died of the disease. The median age of individuals with NHL has risen in the past 2 decades, resulting in a patient population that may also have significant comorbid conditions, complicating treatment options. These guidelines reflect significant updates, including the addition of a new guideline for adult T-cell leukemia/lymphoma, modifications to several treatment options for various lymphomas, and the inclusion of new therapies that recently received FDA approval.",

keywords = "Chronic lymphocytic leukemia, Cutaneous T-cell lymphoma, Diagnosis, Diffuse large B-cell lymphoma, Follicular lymphoma, Hematopathology, Immunohistochemistry, Lymphoma pathology, Mantle cell lymphoma, Marginal zone lymphoma, Mucosa-associated lymphoid tissue lymphoma, Mycosis fungoides, NCCN clinical practice guidelines, Non-Hodgkin's lymphoma, Peripheral, Staging evaluation, S{\'e}zary syndrome, T-cell lymphoma, Treatment, Treatment guidelines",

author = "Zelenetz, {Andrew D.} and Abramson, {Jeremy S.} and Advani, {Ranjana H.} and {Babis Andreadis}, C. and Byrd, {John C.} and Czuczman, {Myron S.} and Luis Fayad and Andres Forero and Glenn, {Martha J.} and Gockerman, {Jon P.} and Gordon, {Leo I.} and Harris, {Nancy Lee} and Hoppe, {Richard T.} and Horwitz, {Steven M.} and Kaminski, {Mark S.} and Kim, {Youn H.} and Lacasce, {Ann S.} and Mughal, {Tariq I.} and Auyporn Nademanee and Pierluigi Porcu and Oliver Press and Leonard Prosnitz and Nashitha Reddy and Smith, {Mitchell R.} and Lubomir Sokol and Lode Swinnen and Vose, {Julie M.} and Wierda, {William G.} and Joachim Yahalom and Furhan Yunus",

year = "2010",

month = mar,

doi = "10.6004/jnccn.2010.0021",

language = "English (US)",

volume = "8",

pages = "288--334",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "3",

}

TY - JOUR

T1 - Non-Hodgkin's lymphomas clinical practice guidelines in oncology

AU - Zelenetz, Andrew D.

AU - Abramson, Jeremy S.

AU - Advani, Ranjana H.

AU - Babis Andreadis, C.

AU - Byrd, John C.

AU - Czuczman, Myron S.

AU - Fayad, Luis

AU - Forero, Andres

AU - Glenn, Martha J.

AU - Gockerman, Jon P.

AU - Gordon, Leo I.

AU - Harris, Nancy Lee

AU - Hoppe, Richard T.

AU - Horwitz, Steven M.

AU - Kaminski, Mark S.

AU - Kim, Youn H.

AU - Lacasce, Ann S.

AU - Mughal, Tariq I.

AU - Nademanee, Auyporn

AU - Porcu, Pierluigi

AU - Press, Oliver

AU - Prosnitz, Leonard

AU - Reddy, Nashitha

AU - Smith, Mitchell R.

AU - Sokol, Lubomir

AU - Swinnen, Lode

AU - Vose, Julie M.

AU - Wierda, William G.

AU - Yahalom, Joachim

AU - Yunus, Furhan

PY - 2010/3

Y1 - 2010/3

N2 - Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of lymphoproliferative disorders originating in B-lymphocytes, T-lymphocytes, or natural killer lymphocytes. An estimated 65,980 new cases of NHL were diagnosed in 2009, and 19,500 patients died of the disease. The median age of individuals with NHL has risen in the past 2 decades, resulting in a patient population that may also have significant comorbid conditions, complicating treatment options. These guidelines reflect significant updates, including the addition of a new guideline for adult T-cell leukemia/lymphoma, modifications to several treatment options for various lymphomas, and the inclusion of new therapies that recently received FDA approval.

AB - Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of lymphoproliferative disorders originating in B-lymphocytes, T-lymphocytes, or natural killer lymphocytes. An estimated 65,980 new cases of NHL were diagnosed in 2009, and 19,500 patients died of the disease. The median age of individuals with NHL has risen in the past 2 decades, resulting in a patient population that may also have significant comorbid conditions, complicating treatment options. These guidelines reflect significant updates, including the addition of a new guideline for adult T-cell leukemia/lymphoma, modifications to several treatment options for various lymphomas, and the inclusion of new therapies that recently received FDA approval.

KW - Chronic lymphocytic leukemia

KW - Cutaneous T-cell lymphoma

KW - Diagnosis

KW - Diffuse large B-cell lymphoma

KW - Follicular lymphoma

KW - Hematopathology

KW - Immunohistochemistry

KW - Lymphoma pathology

KW - Mantle cell lymphoma

KW - Marginal zone lymphoma

KW - Mucosa-associated lymphoid tissue lymphoma

KW - Mycosis fungoides

KW - NCCN clinical practice guidelines

KW - Non-Hodgkin's lymphoma

KW - Peripheral

KW - Staging evaluation

KW - Sézary syndrome

KW - T-cell lymphoma

KW - Treatment

KW - Treatment guidelines

UR - http://www.scopus.com/inward/record.url?scp=77949822338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949822338&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2010.0021

DO - 10.6004/jnccn.2010.0021

M3 - Review article

C2 - 20202462

AN - SCOPUS:77949822338

SN - 1540-1405

VL - 8

SP - 288

EP - 334

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 3

ER -

Non-Hodgkin's lymphomas clinical practice guidelines in oncology

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this